ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Children Respiratory Syncytial Virus Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-1U16759
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Children Respiratory Syncytial Virus Therapeutics Market Research Report 2024
BUY CHAPTERS

Global Children Respiratory Syncytial Virus Therapeutics Market Research Report 2025

Code: QYRE-Auto-1U16759
Report
September 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
F Hoffmann La Roche Ltd
Astrazeneca plc
Merck& Co. Inc
AbbVie
GlaxoSmithKline PLC
ReViral
Teva Pharmaceuticals Industries Ltd
Merck& Co. Inc

Children Respiratory Syncytial Virus Therapeutics Market

The global market for Children Respiratory Syncytial Virus Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Children Respiratory Syncytial Virus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Children Respiratory Syncytial Virus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Children Respiratory Syncytial Virus Therapeutics include F.Hoffmann-La Roche Ltd., AstraZeneca plc, Merck & Co.,Inc., AbbVie, Inc., Valeant Pharmaceuticals International, Inc., GlaxoSmithKline plc, ReViral Ltd., Gilead Sciences, Inc., Medivir AB, Teva Pharmaceuticals Industries Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Children Respiratory Syncytial Virus Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Respiratory Syncytial Virus Therapeutics.
The Children Respiratory Syncytial Virus Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Children Respiratory Syncytial Virus Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Children Respiratory Syncytial Virus Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Children Respiratory Syncytial Virus Therapeutics Market Report

Report Metric Details
Report Name Children Respiratory Syncytial Virus Therapeutics Market
Segment by Type
  • Oral
  • lnjectable
  • Others
Segment by Application
  • Drug Stores and Retail Pharmacies
  • Hospital Pharmacies
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company F.Hoffmann-La Roche Ltd., AstraZeneca plc, Merck & Co.,Inc., AbbVie, Inc., Valeant Pharmaceuticals International, Inc., GlaxoSmithKline plc, ReViral Ltd., Gilead Sciences, Inc., Medivir AB, Teva Pharmaceuticals Industries Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Children Respiratory Syncytial Virus Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Children Respiratory Syncytial Virus Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Children Respiratory Syncytial Virus Therapeutics Market report?

Ans: The main players in the Children Respiratory Syncytial Virus Therapeutics Market are F.Hoffmann-La Roche Ltd., AstraZeneca plc, Merck & Co.,Inc., AbbVie, Inc., Valeant Pharmaceuticals International, Inc., GlaxoSmithKline plc, ReViral Ltd., Gilead Sciences, Inc., Medivir AB, Teva Pharmaceuticals Industries Ltd.

What are the Application segmentation covered in the Children Respiratory Syncytial Virus Therapeutics Market report?

Ans: The Applications covered in the Children Respiratory Syncytial Virus Therapeutics Market report are Drug Stores and Retail Pharmacies, Hospital Pharmacies, Others

What are the Type segmentation covered in the Children Respiratory Syncytial Virus Therapeutics Market report?

Ans: The Types covered in the Children Respiratory Syncytial Virus Therapeutics Market report are Oral, lnjectable, Others

1 Children Respiratory Syncytial Virus Therapeutics Market Overview
1.1 Product Definition
1.2 Children Respiratory Syncytial Virus Therapeutics by Type
1.2.1 Global Children Respiratory Syncytial Virus Therapeutics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 lnjectable
1.2.4 Others
1.3 Children Respiratory Syncytial Virus Therapeutics by Application
1.3.1 Global Children Respiratory Syncytial Virus Therapeutics Market Value by Application (2024 VS 2031)
1.3.2 Drug Stores and Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Others
1.4 Global Children Respiratory Syncytial Virus Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Children Respiratory Syncytial Virus Therapeutics Revenue 2020-2031
1.4.2 Global Children Respiratory Syncytial Virus Therapeutics Sales 2020-2031
1.4.3 Global Children Respiratory Syncytial Virus Therapeutics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Children Respiratory Syncytial Virus Therapeutics Market Competition by Manufacturers
2.1 Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Children Respiratory Syncytial Virus Therapeutics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Children Respiratory Syncytial Virus Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Children Respiratory Syncytial Virus Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Children Respiratory Syncytial Virus Therapeutics, Product Type & Application
2.7 Global Key Manufacturers of Children Respiratory Syncytial Virus Therapeutics, Date of Enter into This Industry
2.8 Global Children Respiratory Syncytial Virus Therapeutics Market Competitive Situation and Trends
2.8.1 Global Children Respiratory Syncytial Virus Therapeutics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Children Respiratory Syncytial Virus Therapeutics Players Market Share by Revenue
2.8.3 Global Children Respiratory Syncytial Virus Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Children Respiratory Syncytial Virus Therapeutics Market Scenario by Region
3.1 Global Children Respiratory Syncytial Virus Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Children Respiratory Syncytial Virus Therapeutics Sales by Region: 2020-2031
3.2.1 Global Children Respiratory Syncytial Virus Therapeutics Sales by Region: 2020-2025
3.2.2 Global Children Respiratory Syncytial Virus Therapeutics Sales by Region: 2026-2031
3.3 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Region: 2020-2031
3.3.1 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Region: 2020-2025
3.3.2 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Region: 2026-2031
3.4 North America Children Respiratory Syncytial Virus Therapeutics Market Facts & Figures by Country
3.4.1 North America Children Respiratory Syncytial Virus Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Children Respiratory Syncytial Virus Therapeutics Sales by Country (2020-2031)
3.4.3 North America Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Children Respiratory Syncytial Virus Therapeutics Market Facts & Figures by Country
3.5.1 Europe Children Respiratory Syncytial Virus Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Children Respiratory Syncytial Virus Therapeutics Sales by Country (2020-2031)
3.5.3 Europe Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Children Respiratory Syncytial Virus Therapeutics Market Facts & Figures by Region
3.6.1 Asia Pacific Children Respiratory Syncytial Virus Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Children Respiratory Syncytial Virus Therapeutics Sales by Region (2020-2031)
3.6.3 Asia Pacific Children Respiratory Syncytial Virus Therapeutics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Children Respiratory Syncytial Virus Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Children Respiratory Syncytial Virus Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Children Respiratory Syncytial Virus Therapeutics Sales by Country (2020-2031)
3.7.3 Latin America Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Children Respiratory Syncytial Virus Therapeutics Sales by Type (2020-2031)
4.1.1 Global Children Respiratory Syncytial Virus Therapeutics Sales by Type (2020-2025)
4.1.2 Global Children Respiratory Syncytial Virus Therapeutics Sales by Type (2026-2031)
4.1.3 Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Type (2020-2031)
4.2 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Type (2020-2031)
4.2.1 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Type (2020-2025)
4.2.2 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Type (2026-2031)
4.2.3 Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Type (2020-2031)
4.3 Global Children Respiratory Syncytial Virus Therapeutics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Children Respiratory Syncytial Virus Therapeutics Sales by Application (2020-2031)
5.1.1 Global Children Respiratory Syncytial Virus Therapeutics Sales by Application (2020-2025)
5.1.2 Global Children Respiratory Syncytial Virus Therapeutics Sales by Application (2026-2031)
5.1.3 Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Application (2020-2031)
5.2 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Application (2020-2031)
5.2.1 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Application (2020-2025)
5.2.2 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Application (2026-2031)
5.2.3 Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Application (2020-2031)
5.3 Global Children Respiratory Syncytial Virus Therapeutics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 F.Hoffmann-La Roche Ltd.
6.1.1 F.Hoffmann-La Roche Ltd. Company Information
6.1.2 F.Hoffmann-La Roche Ltd. Description and Business Overview
6.1.3 F.Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 F.Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.1.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates
6.2 AstraZeneca plc
6.2.1 AstraZeneca plc Company Information
6.2.2 AstraZeneca plc Description and Business Overview
6.2.3 AstraZeneca plc Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca plc Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.2.5 AstraZeneca plc Recent Developments/Updates
6.3 Merck & Co.,Inc.
6.3.1 Merck & Co.,Inc. Company Information
6.3.2 Merck & Co.,Inc. Description and Business Overview
6.3.3 Merck & Co.,Inc. Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck & Co.,Inc. Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.3.5 Merck & Co.,Inc. Recent Developments/Updates
6.4 AbbVie, Inc.
6.4.1 AbbVie, Inc. Company Information
6.4.2 AbbVie, Inc. Description and Business Overview
6.4.3 AbbVie, Inc. Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AbbVie, Inc. Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.4.5 AbbVie, Inc. Recent Developments/Updates
6.5 Valeant Pharmaceuticals International, Inc.
6.5.1 Valeant Pharmaceuticals International, Inc. Company Information
6.5.2 Valeant Pharmaceuticals International, Inc. Description and Business Overview
6.5.3 Valeant Pharmaceuticals International, Inc. Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Valeant Pharmaceuticals International, Inc. Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.5.5 Valeant Pharmaceuticals International, Inc. Recent Developments/Updates
6.6 GlaxoSmithKline plc
6.6.1 GlaxoSmithKline plc Company Information
6.6.2 GlaxoSmithKline plc Description and Business Overview
6.6.3 GlaxoSmithKline plc Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GlaxoSmithKline plc Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.6.5 GlaxoSmithKline plc Recent Developments/Updates
6.7 ReViral Ltd.
6.7.1 ReViral Ltd. Company Information
6.7.2 ReViral Ltd. Description and Business Overview
6.7.3 ReViral Ltd. Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ReViral Ltd. Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.7.5 ReViral Ltd. Recent Developments/Updates
6.8 Gilead Sciences, Inc.
6.8.1 Gilead Sciences, Inc. Company Information
6.8.2 Gilead Sciences, Inc. Description and Business Overview
6.8.3 Gilead Sciences, Inc. Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Gilead Sciences, Inc. Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.8.5 Gilead Sciences, Inc. Recent Developments/Updates
6.9 Medivir AB
6.9.1 Medivir AB Company Information
6.9.2 Medivir AB Description and Business Overview
6.9.3 Medivir AB Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medivir AB Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.9.5 Medivir AB Recent Developments/Updates
6.10 Teva Pharmaceuticals Industries Ltd.
6.10.1 Teva Pharmaceuticals Industries Ltd. Company Information
6.10.2 Teva Pharmaceuticals Industries Ltd. Description and Business Overview
6.10.3 Teva Pharmaceuticals Industries Ltd. Children Respiratory Syncytial Virus Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceuticals Industries Ltd. Children Respiratory Syncytial Virus Therapeutics Product Portfolio
6.10.5 Teva Pharmaceuticals Industries Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Children Respiratory Syncytial Virus Therapeutics Industry Chain Analysis
7.2 Children Respiratory Syncytial Virus Therapeutics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Children Respiratory Syncytial Virus Therapeutics Production Mode & Process Analysis
7.4 Children Respiratory Syncytial Virus Therapeutics Sales and Marketing
7.4.1 Children Respiratory Syncytial Virus Therapeutics Sales Channels
7.4.2 Children Respiratory Syncytial Virus Therapeutics Distributors
7.5 Children Respiratory Syncytial Virus Therapeutics Customer Analysis
8 Children Respiratory Syncytial Virus Therapeutics Market Dynamics
8.1 Children Respiratory Syncytial Virus Therapeutics Industry Trends
8.2 Children Respiratory Syncytial Virus Therapeutics Market Drivers
8.3 Children Respiratory Syncytial Virus Therapeutics Market Challenges
8.4 Children Respiratory Syncytial Virus Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
F Hoffmann La Roche Ltd
Astrazeneca plc
Merck& Co. Inc
AbbVie
GlaxoSmithKline PLC
ReViral
Teva Pharmaceuticals Industries Ltd
Merck& Co. Inc
List of Tables
 Table 1. Global Children Respiratory Syncytial Virus Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Children Respiratory Syncytial Virus Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Children Respiratory Syncytial Virus Therapeutics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Children Respiratory Syncytial Virus Therapeutics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Children Respiratory Syncytial Virus Therapeutics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Children Respiratory Syncytial Virus Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Children Respiratory Syncytial Virus Therapeutics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Children Respiratory Syncytial Virus Therapeutics, Product Type & Application
 Table 12. Global Key Manufacturers of Children Respiratory Syncytial Virus Therapeutics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Children Respiratory Syncytial Virus Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Respiratory Syncytial Virus Therapeutics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Children Respiratory Syncytial Virus Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Children Respiratory Syncytial Virus Therapeutics Sales by Region (2020-2025) & (K Units)
 Table 18. Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Region (2020-2025)
 Table 19. Global Children Respiratory Syncytial Virus Therapeutics Sales by Region (2026-2031) & (K Units)
 Table 20. Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Region (2026-2031)
 Table 21. Global Children Respiratory Syncytial Virus Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Region (2020-2025)
 Table 23. Global Children Respiratory Syncytial Virus Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Region (2026-2031)
 Table 25. North America Children Respiratory Syncytial Virus Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Children Respiratory Syncytial Virus Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 27. North America Children Respiratory Syncytial Virus Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 28. North America Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Children Respiratory Syncytial Virus Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Children Respiratory Syncytial Virus Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Children Respiratory Syncytial Virus Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Children Respiratory Syncytial Virus Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Children Respiratory Syncytial Virus Therapeutics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Children Respiratory Syncytial Virus Therapeutics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Children Respiratory Syncytial Virus Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Children Respiratory Syncytial Virus Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Children Respiratory Syncytial Virus Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Children Respiratory Syncytial Virus Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Children Respiratory Syncytial Virus Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units) by Type (2020-2025)
 Table 51. Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units) by Type (2026-2031)
 Table 52. Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Type (2020-2025)
 Table 53. Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Type (2026-2031)
 Table 54. Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Type (2020-2025)
 Table 57. Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Type (2026-2031)
 Table 58. Global Children Respiratory Syncytial Virus Therapeutics Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Children Respiratory Syncytial Virus Therapeutics Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units) by Application (2020-2025)
 Table 61. Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units) by Application (2026-2031)
 Table 62. Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Application (2020-2025)
 Table 63. Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Application (2026-2031)
 Table 64. Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Application (2020-2025)
 Table 67. Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Application (2026-2031)
 Table 68. Global Children Respiratory Syncytial Virus Therapeutics Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Children Respiratory Syncytial Virus Therapeutics Price (US$/Unit) by Application (2026-2031)
 Table 70. F.Hoffmann-La Roche Ltd. Company Information
 Table 71. F.Hoffmann-La Roche Ltd. Description and Business Overview
 Table 72. F.Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. F.Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus Therapeutics Product
 Table 74. F.Hoffmann-La Roche Ltd. Recent Developments/Updates
 Table 75. AstraZeneca plc Company Information
 Table 76. AstraZeneca plc Description and Business Overview
 Table 77. AstraZeneca plc Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca plc Children Respiratory Syncytial Virus Therapeutics Product
 Table 79. AstraZeneca plc Recent Developments/Updates
 Table 80. Merck & Co.,Inc. Company Information
 Table 81. Merck & Co.,Inc. Description and Business Overview
 Table 82. Merck & Co.,Inc. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck & Co.,Inc. Children Respiratory Syncytial Virus Therapeutics Product
 Table 84. Merck & Co.,Inc. Recent Developments/Updates
 Table 85. AbbVie, Inc. Company Information
 Table 86. AbbVie, Inc. Description and Business Overview
 Table 87. AbbVie, Inc. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AbbVie, Inc. Children Respiratory Syncytial Virus Therapeutics Product
 Table 89. AbbVie, Inc. Recent Developments/Updates
 Table 90. Valeant Pharmaceuticals International, Inc. Company Information
 Table 91. Valeant Pharmaceuticals International, Inc. Description and Business Overview
 Table 92. Valeant Pharmaceuticals International, Inc. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Valeant Pharmaceuticals International, Inc. Children Respiratory Syncytial Virus Therapeutics Product
 Table 94. Valeant Pharmaceuticals International, Inc. Recent Developments/Updates
 Table 95. GlaxoSmithKline plc Company Information
 Table 96. GlaxoSmithKline plc Description and Business Overview
 Table 97. GlaxoSmithKline plc Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. GlaxoSmithKline plc Children Respiratory Syncytial Virus Therapeutics Product
 Table 99. GlaxoSmithKline plc Recent Developments/Updates
 Table 100. ReViral Ltd. Company Information
 Table 101. ReViral Ltd. Description and Business Overview
 Table 102. ReViral Ltd. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. ReViral Ltd. Children Respiratory Syncytial Virus Therapeutics Product
 Table 104. ReViral Ltd. Recent Developments/Updates
 Table 105. Gilead Sciences, Inc. Company Information
 Table 106. Gilead Sciences, Inc. Description and Business Overview
 Table 107. Gilead Sciences, Inc. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Gilead Sciences, Inc. Children Respiratory Syncytial Virus Therapeutics Product
 Table 109. Gilead Sciences, Inc. Recent Developments/Updates
 Table 110. Medivir AB Company Information
 Table 111. Medivir AB Description and Business Overview
 Table 112. Medivir AB Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Medivir AB Children Respiratory Syncytial Virus Therapeutics Product
 Table 114. Medivir AB Recent Developments/Updates
 Table 115. Teva Pharmaceuticals Industries Ltd. Company Information
 Table 116. Teva Pharmaceuticals Industries Ltd. Description and Business Overview
 Table 117. Teva Pharmaceuticals Industries Ltd. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Teva Pharmaceuticals Industries Ltd. Children Respiratory Syncytial Virus Therapeutics Product
 Table 119. Teva Pharmaceuticals Industries Ltd. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Children Respiratory Syncytial Virus Therapeutics Distributors List
 Table 123. Children Respiratory Syncytial Virus Therapeutics Customers List
 Table 124. Children Respiratory Syncytial Virus Therapeutics Market Trends
 Table 125. Children Respiratory Syncytial Virus Therapeutics Market Drivers
 Table 126. Children Respiratory Syncytial Virus Therapeutics Market Challenges
 Table 127. Children Respiratory Syncytial Virus Therapeutics Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Children Respiratory Syncytial Virus Therapeutics
 Figure 2. Global Children Respiratory Syncytial Virus Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Children Respiratory Syncytial Virus Therapeutics Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. lnjectable Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Children Respiratory Syncytial Virus Therapeutics Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Children Respiratory Syncytial Virus Therapeutics Market Share by Application: 2024 & 2031
 Figure 9. Drug Stores and Retail Pharmacies
 Figure 10. Hospital Pharmacies
 Figure 11. Others
 Figure 12. Global Children Respiratory Syncytial Virus Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Children Respiratory Syncytial Virus Therapeutics Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Children Respiratory Syncytial Virus Therapeutics Sales (2020-2031) & (K Units)
 Figure 15. Global Children Respiratory Syncytial Virus Therapeutics Average Price (US$/Unit) & (2020-2031)
 Figure 16. Children Respiratory Syncytial Virus Therapeutics Report Years Considered
 Figure 17. Children Respiratory Syncytial Virus Therapeutics Sales Share by Manufacturers in 2024
 Figure 18. Global Children Respiratory Syncytial Virus Therapeutics Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Children Respiratory Syncytial Virus Therapeutics Players: Market Share by Revenue in Children Respiratory Syncytial Virus Therapeutics in 2024
 Figure 20. Children Respiratory Syncytial Virus Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Children Respiratory Syncytial Virus Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Country (2020-2031)
 Figure 23. North America Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 24. United States Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Country (2020-2031)
 Figure 27. Europe Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 35. China Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Children Respiratory Syncytial Virus Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Children Respiratory Syncytial Virus Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Children Respiratory Syncytial Virus Therapeutics by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Children Respiratory Syncytial Virus Therapeutics by Type (2020-2031)
 Figure 54. Global Children Respiratory Syncytial Virus Therapeutics Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Children Respiratory Syncytial Virus Therapeutics by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Children Respiratory Syncytial Virus Therapeutics by Application (2020-2031)
 Figure 57. Global Children Respiratory Syncytial Virus Therapeutics Price (US$/Unit) by Application (2020-2031)
 Figure 58. Children Respiratory Syncytial Virus Therapeutics Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Respiratory Syncytial Virus Therapeutic Drugs Market Research Report 2024
Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024
Global Respiratory Syncytial Virus Treatment Market Research Report 2024
Anti Respiratory Syncytial Virus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Respiratory Syncytial Virus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus Vaccine for the Elderly Market Research Report 2024
Respiratory Syncytial Virus RSV Infections Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus Fusion Protein Drug Market Research Report 2024
Pediatric Respiratory Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus RSV Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus RSV Antigen and Antibody Reagent Market Research Report 2024
Global Respiratory Virus Vaccines Market Research Report 2024
Respiratory Virus Infection Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Clinical Trials Market Research Report 2024
Global Respiratory Antiviral Treatment Market Research Report 2024
Vaccines For Children VFC Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatrics Respiratory Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions